BioPorto A/S (CPH:BIOPOR)
Denmark · Delayed Price · Currency is DKK 1.134
-0.018 (-1.56%)
At close: Dec 5, 2025
BioPorto Market Cap
BioPorto has a market cap or net worth of 561.44 million as of December 5, 2025. Its market cap has decreased by -22.22% in one year.
Market Cap
561.44M
Enterprise Value
542.18M
Revenue
36.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.13
Market Cap Chart
Since March 1, 2005, BioPorto's market cap has increased from 75.28M to 561.44M, an increase of 645.81%. That is a compound annual growth rate of 10.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 561.44M | -15.70% |
| Dec 30, 2024 | 665.97M | -16.07% |
| Dec 29, 2023 | 793.48M | 2.41% |
| Dec 30, 2022 | 774.78M | 17.16% |
| Dec 30, 2021 | 661.32M | -38.59% |
| Dec 30, 2020 | 1.08B | 110.11% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.38T |
| Coloplast | 131.88B |
| Genmab | 125.17B |
| ALK-Abelló | 50.74B |
| Demant | 46.10B |
| H. Lundbeck | 42.14B |
| Zealand Pharma | 35.55B |
| Ambu A/S | 23.26B |